Target intelligence / Profile preview

YKT6 vesicular SNARE protein (YKT6)

Target
YKT6
Molecular classification
SNARE protein, R-SNARE, Membrane-trafficking protein
01

Overview

YKT6 vesicular SNARE protein is a conserved R-SNARE critical for membrane fusion along multiple intracellular vesicular trafficking pathways. Ykt6 is unique among SNAREs, as it reversibly cycles between cytosolic and membrane-associated states through post-translational lipidation (palmitoylation, farnesylation, and geranylgeranylation) rather than a canonical transmembrane domain[1][6]. This dynamic localization is regulated by its N-terminal longin domain, which mediates autoinhibition through intramolecular interaction with the SNARE domain. Activation of Ykt6 involves conformational switches, often regulated by phosphorylation, that expose its lipid anchor for membrane association and permit SNARE complex assembly[1][4][6]. Ykt6 mediates key fusion events in the secretory pathway, Golgi retrograde transport, and particularly in autophagosome-lysosome fusion in both yeast and animals[2][3][6]. It is highly expressed in neurons, where it contributes to specialized vesicle trafficking and may be involved in unique lysosome-like compartments[5]. Ykt6 dysfunction (including its interaction with pathogenic α-synuclein species) disrupts normal trafficking, impairs autophagy, and is implicated in the pathogenesis of synucleinopathies such as Parkinson’s disease[1]. No current drugs directly target Ykt6, but its molecular function positions it as a candidate for therapeutic modulation in autophagy and neurodegeneration research[1][6].

Other names
Ykt6p (in yeast)Vesicular SNARE protein Ykt6
02

Mechanism of action

Modulation of YKT6 (e.g., via phosphorylation) affects its conformation, leading to altered vesicle trafficking and fusion processes. Dysregulation via interactions with α-synuclein aggravates toxicity in disease models.

03

Biological functions

Vesicle fusion and membrane traffickingRegulation of autophagosome-lysosome fusionRetrograde transport to the cis-GolgiNeuronal secretion and autophagyProtein palmitoylation regulation
04

Disease associations

Neurodegenerative disease (Parkinson’s disease and synucleinopathies)Other potential roles in diseases related to vesicle trafficking, although direct associations are primarily studied in neurodegeneration
05

Safety considerations

Interference in Ykt6 function could disrupt essential vesicle trafficking, leading to toxicity or cell death
06

Biomarkers

Changes in Ykt6 levelsYkt6 phosphorylation stateYkt6 localization

Beyond the preview

Go deeper on YKT6 vesicular SNARE protein (YKT6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on YKT6 vesicular SNARE protein (YKT6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call